SRSTOCK RADAR

Today

July 25, 2026

Today's Alerts

10Last 24H

Dilution Risk

5Last 7D

Listing Risk

37Last 30D

Earnings

9Last 7D

Insider / Ownership

3Last 14D

Dividends

1Last 30D

FDA / Clinical

7Last 30D
IVFN/A+0.00%
Financial Risk
INVO Fertility Late Filing Due to Audit Delay

INVO Fertility's 10-Q is delayed due to auditor transition and complex accounting reviews, impacting financial statement finalization.

bearishImpact 65
ISPCN/A+0.00%
Financial Risk
iSpecimen Inc. reports a 85.25% decrease in Q1 2026 revenue and a 37.20% increase in net loss, raising substantial doubt about its ability to continue as a going concern.

iSpecimen Inc. reported a severe 85.25% drop in Q1 2026 revenue and a 37.20% increase in net loss, prompting a going concern warning due to recurring losses and negative working capital.

bearishImpact 85
APUSN/A+0.00%
Financial Risk
Apimeds Pharmaceuticals US, Inc. reports a 332.5% increase in net loss to $6.0 million and a 1117.0% increase in cash used in operations to $8.9 million in FY 2025, raising substantial doubt about its going concern ability.

Apimeds Pharmaceuticals US, Inc.

bearishImpact 85
WOKN/A+0.00%
Earnings
WORK Medical Technology Group LTD reports FY2025 revenue decreased 14.4% to $9.85M, net loss narrowed to $1.20M from $3.54M, and operating cash flow turned positive to $6.24M.

WORK Medical Technology Group LTD's FY2025 revenue decreased 14.4% to $9.85 million, but the company significantly narrowed its net loss to $1.20 million and achieved positive operating cash flow of $6.24 million.

bullishImpact 70
ZENAN/A+0.00%
Earnings
ZenaTech's 2025 Revenue Soars 558% to $12.9M Driven by DaaS Segment, but Net Loss Widens to $(45.2)M

ZenaTech's 2025 revenue surged 558% to $12.9M, primarily from its new DaaS segment, but net loss expanded to $(45.2)M due to increased finance, wage, and G&A expenses, with negative operating cash flow.

volatileImpact 75
NBISN/A+0.00%
Earnings
Nebius Group N.V. reports FY 2025 revenue up 479.0% to $529.8M, turns profitable with $82.5M net income, and operating cash flow up 56.7% to $384.8M.

Nebius Group N.V.

volatileImpact 75
WULFN/A+0.00%
Earnings
TeraWulf Inc. reports Q1 2025 revenue decreased 18.9% to $34.4M and net loss widened to $61.4M from $9.6M YoY, driven by higher power costs and network difficulty.

TeraWulf's Q1 2025 results show an 18.9% revenue decrease to $34.4 million and a widened net loss of $61.4 million, primarily due to increased power costs and bitcoin network difficulty, partially offset by strong operating cash flow.

bearishImpact 75
SATLN/A+0.00%
Earnings
Satellogic Inc. Reports Q1 2026 Revenue Up 80.3% to $6.1M, Net Loss Widens to $(118.3)M

Satellogic's Q1 2026 revenue surged 80.3% to $6.1 million, but net loss dramatically widened to $(118.3) million, primarily due to a non-cash fair value adjustment of financial instruments.

volatileImpact 75
ASTSN/A+0.00%
Earnings
AST SpaceMobile Reports Q2 2025 Revenue Up 28.4% to $1.16M, Net Loss Widens to $(99.39)M

AST SpaceMobile reported a 28.4% increase in Q2 2025 revenue to $1.16 million, but net loss widened to $(99.39) million, primarily due to higher operating expenses and a significant loss on warrant liabilities.

bearishImpact 75
TRAWN/A+0.00%
Financial Risk
Traws Pharma reports net income of $9.2M, a significant improvement from a $166.5M net loss, but faces substantial doubt about its...

Traws Pharma reported a net income of $9.2 million for FY2025, a significant turnaround from a $166.5 million net loss in FY2024, primarily due to a non-cash change in warrant liability....

bearishImpact 80
TRAWN/A+0.00%
Financial Risk
Traws Pharma Files NT 10-K Due to Going Concern and Financing Uncertainty

Traws Pharma's 10-K filing is delayed due to ongoing financing efforts and substantial doubt about its ability to continue as a going concern.

bearishImpact 72
NCRAN/A+0.00%
Earnings
Nocera, Inc. Reports 2025 Annual Revenue Decline of 19.9% to $13.6M and Narrows Net Loss by 35.8% to $(2.9)M

Nocera, Inc. reported a 19.9% decrease in annual revenue to $13.6 million for FY2025, while narrowing its net loss by 35.8% to $(2.9) million....

bearishImpact 75
MBRXN/A+0.00%
Earnings
Moleculin Biotech reports FY2025 net loss widened by 28.8% to $(33.56)M; cash up 107.5% to $8.88M

Moleculin Biotech reported a widened net loss of $(33.56)M for FY2025, a 28.8% increase from the prior year. However, cash and cash equivalents surged 107.5% to $8.88M, extending the funding runway into Q3 2026....

volatileImpact 70
CRCLN/A+0.00%
Earnings
Circle Internet Group Reports 63.9% Revenue Growth to $2.75B, but Net Income Turns to a $69.5M Loss in FY2025

Circle Internet Group's FY2025 revenue surged 63.9% to $2.75 billion, but the company posted a net loss of $69.5 million, a significant decline from the prior year's $155.7 million net income, largely due to...

volatileImpact 75
SHOPN/A+0.00%
Earnings
Shopify Inc. Reports 2025 Annual Results: Revenue Up 30.1%, Operating Income Up 36.6%, Net Income Down 39.1%

Shopify reported a 30.1% increase in revenue to $11.56 billion and a 36.6% rise in operating income to $1.47 billion for FY2025....

volatileImpact 70
SPOTN/A+0.00%
Earnings
Spotify Technology S.A. Reports 10.77% Revenue Growth and 94.38% Net Income Increase in FY 2025

Spotify Technology S.A. delivered strong financial results for fiscal year 2025, with revenue up 10.77% to €17.19 billion and net income surging 94.38% to €2.21 billion, driven by Premium subscriber growth.

bullishImpact 68
NION/A+0.00%
Earnings
NIO Inc. Reports 33.1% Revenue Growth to RMB87.49B and 33.3% Net Loss Reduction to RMB14.94B in FY2025

NIO Inc. reported a 33.1% increase in revenues to RMB87.49 billion and a 33.3% reduction in net loss to RMB14.94 billion for FY2025, alongside a shift to positive operating cash flow.

bullishImpact 70
ASMLN/A+0.00%
Earnings
ASML Holding NV Reports Strong FY 2025 Results with 15.6% Revenue Growth and 26.9% Net Income Increase

ASML Holding NV reported a strong fiscal year 2025, with total net sales increasing by 15.6% to €32.7 billion and net income rising 26.9% to €9.61 billion.

bullishImpact 68
HSBCN/A+0.00%
Earnings
HSBC Holdings plc Reports Decline in Annual Operating Profit and Net Income for FY 2025, Sets 2028 Revenue Growth Target

HSBC's annual operating profit and net income declined in FY 2025, with a substantial decrease in operating cash flow. The company aims for 5% YoY revenue growth by 2028 and a 17% RoTE, but will pause share buy-backs...

volatileImpact 64
NVON/A+0.00%
Earnings
Novo Nordisk A/S Reports Modest 2025 Net Profit Growth Amid Strong Revenue, Leadership Change, and Ongoing Legal Challenges

Novo Nordisk reported a 6.4% increase in revenue to DKK 309.06 billion for FY 2025, but operating profit slightly decreased by 0.5%. Net profit grew modestly by 1.4% to DKK 102.43 billion....

neutralImpact 62